Provention Bio rakes in $28.4 mln Series A

Provention Bio Inc, a biopharmaceutical company, has secured $28.4 million in Series A funding. The investors included Johnson & Johnson Innovation. MDB Capital Group LLC served as the placement agent.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!